Electrophysiologic Changes and Their Effects on Ventricular Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices

dc.authorid0000-0003-4546-1452
dc.authorid0000-0002-6676-2740
dc.authorid0000-0003-0364-2239
dc.contributor.authorCelik, Mehmet
dc.contributor.authorEmiroglu, Mehmet Yunus
dc.contributor.authorBayram, Zubeyde
dc.contributor.authorIzci, Servet
dc.contributor.authorKaragoz, Ali
dc.contributor.authorAkbal, Ozgur Yasar
dc.contributor.authorKahyaoglu, Muzaffer
dc.date.accessioned2025-05-10T19:38:59Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractVentricular arrhythmias (VAs) continue even after left ventricular assist device (LVAD) implantation. The effect of LVAD on VAs is controversial. We investigated electrophysiologic changes after LVAD and its effects on VAs development. A total of 107 implantable cardioverter-defibrillator (ICD) patients, with LVAD, were included in this study. Electrocardiographic parameters including QRS duration (between the beginning of the QRS complex and the end of the S wave), QT duration (between the first deflection of the QRS complex and the end of the T wave) corrected QT (QTc), QTc dispersion, fragmented QRS (F-QRS), and ICD recordings before, and post-LVAD first year were analyzed. All sustained VAs were classified as polymorphic ventricular tachycardia (PVT) or monomorphic VT (MVT). The QRS, QT, QTc durations, and QTc dispersion had decreased significantly after LVAD implantation (p < 0.001 for all). Also MVT increased significantly from 28.9% to 49.5% (p = 0.019) whereas PVT decreased from 27.1% to 4.67% (p = 0.04) compared to pre-LVAD period. A strong correlation was found between QT shortening and the decrease in PVT occurrence. Besides, the increase in the F-QRS after LVAD was associated with post-LVAD de nova MVT development. Finally, F-QRS before LVAD was found as an independent predictor of post-LVAD late VAs in multivariate analysis. Pre-existing or newly developed F-QRS was associated with post-LVAD late VAs, and it may be used to determine the risk of VAs after LVAD implantation.
dc.identifier.doi10.1097/MAT.0000000000001472
dc.identifier.endpage348
dc.identifier.issn1058-2916
dc.identifier.issn1538-943X
dc.identifier.issue3
dc.identifier.pmid35213883
dc.identifier.scopus2-s2.0-85125548406
dc.identifier.scopusqualityQ2
dc.identifier.startpage341
dc.identifier.urihttps://doi.org/10.1097/MAT.0000000000001472
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9530
dc.identifier.volume68
dc.identifier.wosWOS:000760976300014
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofAsaio Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectheart failure
dc.subjectleft ventricular assist device
dc.subjectventricular arrhythmias
dc.titleElectrophysiologic Changes and Their Effects on Ventricular Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9530
Boyut:
565.92 KB
Biçim:
Adobe Portable Document Format